New drug shows promise for rare heart condition in chinese patients
NCT ID NCT06194825
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called eplontersen in Chinese adults with a heart condition caused by abnormal protein buildup. The goal is to see if the drug lowers that protein and is safe over time. Participants will be randomly assigned to receive the drug or a placebo for 24 weeks, then everyone can get the drug for another 80 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100029, China
-
Research Site
Beijing, 100034, China
-
Research Site
Beijing, 100037, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 100730, China
-
Research Site
Changsha, 410008, China
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, 430033, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chengdu, 610072, China
-
Research Site
Chongqing, 400010, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Guangzhou, 510062, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310014, China
-
Research Site
Hangzhou, 310052, China
-
Research Site
Ha’erbin, 150001, China
-
Research Site
Jinan, 250001, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Suzhou, 215006, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Wuhan, 430060, China
-
Research Site
Xi'an, 710061, China